




Instance: composition-en-2551c286e23d3921dbfab879452cee74
InstanceOf: CompositionUvEpi
Title: "Composition for fluad Package Leaflet"
Description:  "Composition for fluad Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp354d06b758c1fa17f5a3268e4de6e468)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - fluad"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Fluad Tetra is and what it is used for  </li>
<li>What you need to know before you receive  Fluad Tetra  </li>
<li>How Fluad Tetra is given  </li>
<li>Possible side effects  </li>
<li>How to store Fluad Tetra </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What fluad is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What fluad is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Fluad Tetra is a vaccine against flu (influenza).<br />
When a person is given the vaccine, the immune system (the body s natural defence system) will 
produce its own protection against the influenza virus. None of the ingredients in the vaccine can 
cause flu.  </p>
<p>Fluad Tetra is used to prevent flu in adults 50 years of age and older. </p>
<p>The vaccine targets four strains of influenza virus following the recommendations by the World 
Health Organisation for the 2023/2024 season. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take fluad"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take fluad"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>You should not receive Fluad Tetra 
- if you are allergic to<br />
  the active substances or any of the other ingredients of this medicine (listed in section 6)<br />
  egg or chicken proteins (such as ovalbumin), kanamycin and neomycin sulphate, formaldehyde, 
cetyltrimethylammonium bromide (CTAB) and hydrocortisone, which are trace residues from 
the manufacturing process. 
- If you have had a severe allergic reaction (e.g. anaphylaxis) to previous influenza vaccination. </p>
<p>Warnings and precautions<br />
Talk to your doctor, pharmacist or nurse before receiving Fluad Tetra. </p>
<p>BEFORE receiving the vaccine 
* Your doctor or nurse will make sure that appropriate medical treatment and supervision is readily 
available in case of a rare anaphylactic reaction (a very severe allergic reaction with symptoms 
such as difficulty in breathing, dizziness, a weak and rapid pulse and skin rash) following the 
administration. This reaction may occur with Fluad Tetra as with all vaccines that are injected. 
* You should tell your doctor if you have an illness associated with fever. Your doctor may decide 
to delay your vaccination until your fever is gone. 
* You should tell your doctor if your immune system is impaired, or if you are undergoing treatment 
which affects the immune system, e.g. with medicine against cancer (chemotherapy) or 
corticosteroid medicines (see Section  Other medicines and Fluad Tetra ). 
* You should tell your doctor if you have a bleeding problem or bruise easily. 
* Fainting can occur following, or even before, any needle injection, therefore tell the doctor or 
nurse if you fainted with a previous injection. </p>
<p>As with all vaccines, Fluad Tetra may not fully protect all persons who are vaccinated. </p>
<p>Children 
Fluad Tetra is not recommended for use in children.  </p>
<p>Other medicines and Fluad Tetra 
Tell your doctor or nurse if you are using, have recently used or might use any other medicines, 
including medicines obtained without a prescription or if you have recently received any other 
vaccine. </p>
<p>Pregnancy and breast-feeding<br />
This vaccine is for use in adults 50 years and older. It is not to be used in women who are, or may be, 
pregnant or breast-feeding. </p>
<p>Driving and using machines 
Fluad Tetra has no or negligible influence on the ability to drive and use machines.  </p>
<p>Fluad Tetra contains potassium and sodium<br />
This vaccine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially  sodium free . 
This vaccine contains potassium, less than 1 mmol (39 mg) per dose, i.e. essentially  potassium free . </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take fluad"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take fluad"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Fluad Tetra is given by your doctor or nurse as an injection into the muscle at the top of the upper arm 
(deltoid muscle). </p>
<p>Adults 50 years of age and older: </p>
<p>One dose of 0.5 ml </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>Tell your doctor immediately or go to the casualty department at your nearest hospital if you 
experience the following serious side effect   you may need urgent medical attention or 
hospitalisation: </p>
<p>Difficulty in breathing, dizziness, a weak and rapid pulse and skin rash which are symptoms of an 
anaphylactic reaction (a very severe allergic reaction) </p>
<p>The following side effects have been reported during clinical trials in adults 50 years of age and older.  </p>
<p>Very common (may affect more than 1 in 10 people): 
* Pain at injection site 
* Fatigue 
* Headache<br />
* Joint pain (arthralgia)1 
* Muscular pain (myalgia)1 
1 reported as Common in elderly subjects 65 years of age and older </p>
<p>Common (may affect up to 1 in 10 people): 
* Redness at injection site (erythema) 
* Hardening of the skin at injection site (induration) 
* Diarrhoea 
* Shivering 
* Nausea 
* Loss of appetite 
* Bruising at injection site (ecchymosis) 
* Flu-like symptoms2 
* Fever (  38 C)3 
2 reported in elderly subjects 65 years of age and older 
3 reported as Uncommon in elderly subjects 65 years of age and older </p>
<p>Uncommon (may affect up to 1 in 100 people): 
* Vomiting 
* Swelling of the glands in the neck, armpit or groin (lymphadenopathy) </p>
<p>Most side effects were mild or moderate and went away within 3 days of appearing. </p>
<p>Next to the above side effects, the following side effects occurred occasionally during general use of 
Fluad Tetra or a similar vaccine in elderly individuals 65 years of age and older. 
* reduction in the number of certain types of particles in the blood called platelets; a low number 
of these can result in excessive bruising or bleeding (thrombocytopenia) 
* swelling, pain and redness at the injection site (injection site cellulitis-like reaction) 
* extensive swelling of injected limb lasting more than one week 
* general weakness or lack of energy (asthenia), generally feeling unwell (malaise) 
* fever (pyrexia) 
* muscular weakness 
* pain on the nerve path (neuralgia), unusual feeling of touch, pain, heat and cold (paraesthesia), 
fits (convulsions), neurological disorders that may result in stiff neck, confusion, numbness, 
pain and weakness of the limbs, loss of balance, loss of reflexes, paralysis of part or all the 
body (encephalomyelitis, neuritis, Guillain-Barr  Syndrome) 
* skin reactions that may spread throughout the body including itchiness of the skin (pruritus, 
urticaria), skin redness (erythema), non-specific rash, severe skin rash (erythema multiforme) 
* swelling most apparent in the head and neck, including the face, lips, tongue, throat or any 
other part of the body (angioedema) 
* blood vessel swelling that may cause skin rashes (vasculitis) and temporary kidney problems 
* fainting, feeling about to faint (syncope, presyncope) </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V. By reporting side effects you can help provide more information on the 
safety of this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store fluad"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store fluad"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Store in a refrigerator (2  C to 8  C). Do not freeze. Discard if the vaccine has been frozen. 
Keep the pre-filled syringe in the outer carton in order to protect from light. </p>
<p>Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The 
expiry date refers to the last day of that month. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Fluad Tetra contains  </p>
<ul>
<li>The active substances are influenza virus surface antigens (haemagglutinin and 
neuraminidase), inactivated, of the following strains*:  </li>
</ul>
<p>per 0.5 ml dose 
A/Victoria/4897/2022 (H1N1)pdm09-like strain<br />
(A/Victoria/4897/2022 IVR-238) 
15 micrograms HA<strong> 
A/Darwin/9/2021 (H3N2)-like strain<br />
(A/Darwin/6/2021 IVR-227) 
15 micrograms HA</strong> 
B/Austria/1359417/2021-like strain 
(B/Austria/1359417/2021 BVR-26) 
15 micrograms HA<strong> 
B/Phuket/3073/2013-like strain 
(B/Phuket/3073/2013 BVR 1B) 
15 micrograms HA</strong> 
<em>propagated in fertilised hens  eggs from healthy chicken flocks and adjuvanted with MF59C.1 
</em>*haemagglutinin </p>
<p>This vaccine complies with the WHO recommendations (Northern Hemisphere) and EU 
recommendation for the 2023/2024 season. </p>
<ul>
<li>
<p>MF59C.1 is included in this vaccine as an adjuvant. Adjuvants are substances included in 
certain vaccines to accelerate, improve and/or prolong the protective effects of the vaccine. 
MF59C.1 is an adjuvant that contains per 0.5 ml dose: squalene (9.75 mg), polysorbate (1.175 mg), sorbitan trioleate (1.175 mg), sodium citrate (0.66 mg) and citric acid (0.04 mg). </p>
</li>
<li>
<p>The other ingredients are sodium chloride, potassium chloride, potassium dihydrogen 
phosphate, disodium phosphate dihydrate, magnesium chloride hexahydrate, calcium chloride 
dihydrate and water for injections.    </p>
</li>
</ul>
<p>What Fluad Tetra looks like and contents of the pack 
Fluad Tetra is a suspension for injection in a pre-filled syringe. Fluad Tetra is a milky-white 
suspension. A single syringe contains 0.5 ml of suspension for injection. Fluad Tetra is available in 
packs containing 1 or 10 pre-filled syringes with or without needles.<br />
Not all pack sizes may be marketed.  </p>
<p>Marketing Authorisation Holder and Manufacturer 
Seqirus Netherlands B.V. 
Paasheuvelweg 28,1105 BJ Amsterdam, Netherlands </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: 
Belgi /Belgique/Belgien 
Seqirus Netherlands B.V.Nederland/Netherlands 
Tel: +31 (0) 20 204 6<br />
Seqirus Netherlands B.V. <br />
 .: +31 (0) 20 204 6 esk  republika 
Seqirus Netherlands B.V. Nizozemsko 
Tel: +31 (0) 20 204 6Danmark 
Seqirus Netherlands B.V. Holland 
Tlf: +31 (0) 20 204 6Deutschland 
Seqirus GmbH Marburg 
Tel: 0800/3601Eesti 
Seqirus Netherlands B.V. Holland 
Tel: +31 (0) 20 204 6<br />
WIN MEDICA  . . 
 : 210 7488Espa a 
Seqirus Spain, S.L., Barcelona 
Tel: 937 817 France 
Seqirus Netherlands B.V. Netherlands 
T l: +31 (0) 20 204 6Hrvatska 
Seqirus Netherlands B.V. Nizozemska 
Tel: +31 (0) 20 204 6Ireland 
Seqirus UK Limited Maidenhead 
Tel: +44 1628 641  sland 
Seqirus Netherlands B.V. Holland 
S mi: +31 (0) 20 204 6Italia 
Seqirus S.r.l. Siena 
Tel: +39 0577 096<br />
Seqirus Netherlands B.V. <br />
 : +31 (0) 20 204 6Lietuva 
Seqirus Netherlands B.V. Nyderlandai 
Tel: +31 (0) 20 204 6Luxembourg/Luxemburg 
Seqirus Netherlands B.V. Netherlands 
T l/Tel: +31 (0) 20 204 6Magyarorsz g 
Seqirus Netherlands B.V. Hollandia 
Tel.: +31 (0) 20 204 6Malta 
Seqirus Netherlands B.V. In-Netherlands 
Tel: +31 (0) 20 204 6Nederland 
Seqirus Netherlands B.V. Amsterdam 
Tel: +31 (0) 20 204 6Norge 
Seqirus Netherlands B.V. Nederland 
Tlf: +31 (0) 20 204 6 sterreich 
Valneva Austria GmbH, Wien 
Tel: +43 1 20620 2Polska 
Seqirus Netherlands B.V. Holandia 
Tel.: +31 (0) 20 204 6Portugal 
Seqirus Netherlands B.V. Pa ses Baixos 
Tel: +31 (0) 20 204 6Rom nia 
Seqirus Netherlands B.V. Olanda 
Tel: +31 (0) 20 204 6Slovenija 
Seqirus Netherlands B.V. Nizozemska 
Tel: +31 (0) 20 204 6Slovensk  republika 
Seqirus Netherlands B.V. Holandsko 
Tel: +31 (0) 20 204 6Suomi/Finland 
Seqirus Netherlands B.V. Alankomaat 
Puh/Tel: +31 (0) 20 204 6Sverige 
Seqirus Netherlands B.V. Nederl nderna 
Tel: +31 (0) 20 204 6Latvija 
Seqirus Netherlands B.V. N derlande 
Tel: +31 (0) 20 204 6This leaflet was last revised in {MM/YYYY}. </p>
<p>Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-2551c286e23d3921dbfab879452cee74
InstanceOf: CompositionUvEpi
Title: "Composition for fluad Package Leaflet"
Description:  "Composition for fluad Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp354d06b758c1fa17f5a3268e4de6e468)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - fluad"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Virkning og anvendelse<br />
2. Det skal du vide, før du får Fluad Tetra 
3. Sådan gives Fluad Tetra 
4. Bivirkninger 
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger </p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What fluad is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What fluad is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Fluad Tetra er en vaccine mod influenza.<br />
Når en person får vaccinen, vil immunsystemet (kroppens naturlige forsvarssystem) danne sin egen 
beskyttelse mod influenzavirus. Ingen af indholdsstofferne i vaccinen kan forårsage influenza. </p>
<p>Fluad Tetra anvendes til at forebygge influenza hos voksne på 50 år og derover. </p>
<p>Vaccinen er rettet mod fire influenzavirusstammer efter Verdenssundhedsorganisationens (WHO’s) 
anbefalinger for sæsonen 2023/2024. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take fluad"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take fluad"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Du bør ikke få Fluad Tetra 
- Hvis du er allergisk over for:<br />
• de aktive indholdsstoffer eller et af de øvrige indholdsstoffer i Fluad Tetra (angivet i punkt 6),<br />
• æg eller kyllingeproteiner (såsom ovalbumin), kanamycin og neomycinsulfat, formaldehyd, 
cetyltrimethylammoniumbromid (CTAB) og hydrocortison, som er sporrester fra 
fremstillingsprocessen. 
- Hvis du har haft en svær allergisk reaktion (f.eks. anafylaksi) på en tidligere influenzavaccination. </p>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen, apotekspersonalet eller sygeplejersken, før du får Fluad Tetra. </p>
<p>FØR du får vaccinen </p>
<ul>
<li>
<p>Din læge eller sygeplejerske vil sørge for, at den rette behandling og overvågning er 
umiddelbart tilgængelig i tilfælde af, at vaccinen skulle fremkalde en voldsom allergisk reaktion 
(anafylaktisk reaktion med symptomer som vejrtrækningsbesvær, svimmelhed, svag og hurtig 
puls og udslæt). En sådan reaktion opstår sjældent, men den kan forekomme med Fluad Tetra 
ligesom med alle andre vacciner, der indsprøjtes. </p>
</li>
<li>
<p>Du skal fortælle det til lægen, hvis du har en sygdom, der er forbundet med feber. Lægen kan 
beslutte at udsætte din vaccination, til feberen har fortaget sig. </p>
</li>
<li>
<p>Du skal fortælle det til lægen, hvis dit immunforsvar er nedsat, eller hvis du er i behandling med 
medicin, som påvirker immunforsvaret, f.eks. medicin mod kræft (kemoterapi) eller medicin, 
der indeholder kortikosteroid (se punktet "Brug af anden medicin sammen med Fluad Tetra").  </p>
</li>
<li>
<p>Du skal fortælle det til lægen, hvis du har et blødningsproblem eller let får blå mærker. </p>
</li>
<li>
<p>Der kan forekomme besvimmelse efter eller endda før en kanyleinjektion. Du skal derfor 
fortælle det til lægen eller sygeplejersken, hvis du er besvimet ved en tidligere indsprøjtning. </p>
</li>
</ul>
<p>Som det gælder for alle vacciner, giver Fluad Tetra muligvis ikke fuldstændig beskyttelse for alle 
personer, der vaccineres. </p>
<p>Børn 
Fluad Tetra bør ikke anvendes til børn. </p>
<p>Brug af andre lægemidler sammen med Fluad Tetra 
Fortæl altid lægen eller sygeplejersken, hvis du bruger andre lægemidler, for nylig har brugt andre 
lægemidler eller planlægger at bruge andre lægemidler. Det gælder også medicin, som ikke er købt på 
recept, eller hvis du har fået en anden vaccine for nylig. </p>
<p>Graviditet og amning<br />
Denne vaccine er til anvendelse tilvoksne på 50 år og derover. Den er ikke beregnet til anvendelse til 
kvinder, som er eller kan blive gravid eller ammer. </p>
<p>Trafik- og arbejdssikkerhed 
Fluad Tetra påvirker ikke eller kun i ubetydelig grad evnen til at føre motorkøretøj og betjene 
maskiner.  </p>
<p>Fluad Tetra indeholder kalium og natrium 
Denne vaccine indeholder mindre end 1 mmol (23 mg) natrium pr. dosis, dvs. den er i det væsentlige 
natriumfri. 
Denne vaccine indeholder mindre end 1 mmol (39 mg) kalium pr. dosis, dvs. den er i det væsentlige 
kaliumfri. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take fluad"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take fluad"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Fluad Tetra gives af lægen eller sygeplejersken som en indsprøjtning i musklen øverst på overarmen 
(deltamusklen). </p>
<p>Voksne på 50 år og derover: </p>
<p>Én dosis på 0,5 ml. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Fortæl det straks til lægen eller tag på skadestuen på dit nærmeste hospital, hvis du oplever den 
følgende alvorlige bivirkning - det kan være nødvendigt at give dig akut lægehjælp eller at indlægge 
dig. </p>
<p>• Vejrtrækningsbesvær, svimmelhed, en svag og hurtig puls og hududslæt, hvilket er symptomer på 
en anafylaktisk reaktion (en meget svær allergisk reaktion) </p>
<p>Følgende bivirkninger er blevet rapporteret under kliniske studier hos voksne på 50 år og derover. </p>
<p>Meget almindelige (kan forekomme hos flere end 1 ud af 10 personer): </p>
<ul>
<li>
<p>Smerter på injektionsstedet </p>
</li>
<li>
<p>Træthed </p>
</li>
<li>
<p>Hovedpine  </p>
</li>
<li>
<p>Ledsmerter (artralgi)1 </p>
</li>
<li>
<p>Muskelsmerter (myalgi)1 
1 rapporteret som almindelig hos ældre forsøgspersoner på 65 år og derover </p>
</li>
</ul>
<p>Almindelige (kan forekomme hos op til 1 ud af 10 personer): </p>
<ul>
<li>
<p>Rødme på injektionsstedet (erytem) </p>
</li>
<li>
<p>Hårdhed af huden på injektionsstedet (induration) </p>
</li>
<li>
<p>Diarré </p>
</li>
<li>
<p>Kulderystelser </p>
</li>
<li>
<p>Kvalme </p>
</li>
<li>
<p>Appetitløshed </p>
</li>
<li>
<p>Blodudtrædning/blåt mærke på injektionsstedet (ekkymose) </p>
</li>
<li>
<p>Influenzalignende symptomer2 </p>
</li>
<li>
<p>Feber (≥ 38 °C)3 
2 rapporteret hos ældre forsøgspersoner på 65 år og derover 
3 rapporteret som ikke almindelig hos ældre forsøgspersoner på 65 år og derover  </p>
</li>
</ul>
<p>Ikke almindelige (kan forekomme hos op til 1 ud af 100 personer): </p>
<ul>
<li>
<p>Opkastning </p>
</li>
<li>
<p>Hævede kirtler i hals, armhule eller lyske (lymfadenopati) </p>
</li>
</ul>
<p>De fleste bivirkninger var lette eller moderate og fortog sig inden for 3 dage efter fremkomst. </p>
<p>Foruden ovennævnte bivirkninger er følgende bivirkninger lejlighedsvis forekommet under almindelig 
anvendelse af Fluad Tetra eller en tilsvarende vaccine hos ældre personer på 65 år og derover. </p>
<ul>
<li>
<p>reduktion af antallet af en bestemt type partikler i blodet kaldet blodplader. Et lavt antal af 
disse kan resultere i kraftig blodudtrædning/blå mærker eller blødning (trombocytopeni). </p>
</li>
<li>
<p>hævelse, smerter og rødme på injektionsstedet (cellulitislignende reaktion på injektionsstedet). </p>
</li>
<li>
<p>kraftig hævelse af den injicerede arm/det injicerede ben, der varer mere end én uge. </p>
</li>
<li>
<p>generel svaghed eller manglende energi (asteni), generel utilpashed. </p>
</li>
<li>
<p>feber (pyreksi). </p>
</li>
<li>
<p>muskelsvaghed. </p>
</li>
<li>
<p>smerter i nervebanen (neuralgi), usædvanlig følelse ved berøring, smerter, varme og kulde 
(paræstesi), krampeanfald, neurologiske forstyrrelser, som kan resultere i nakkestivhed, 
forvirring, følelsesløshed, smerter og svaghed i lemmerne, mistet balanceevne, mistede 
reflekser, lammelse af dele af eller hele kroppen (encephalomyelitis, neuritis, Guillain-Barrés 
syndrom). </p>
</li>
<li>
<p>hudreaktioner, der kan sprede sig over hele kroppen, herunder kløe på huden (pruritus, 
urticaria), hudrødme (erytem), ikke-specifikt udslæt, svært hududslæt (erythema multiforme). </p>
</li>
<li>
<p>hævelse, der er mest synlig i hoved og hals, herunder ansigt, læber, tunge, svælg, eller en 
hvilken som helst anden del af kroppen (angioødem). </p>
</li>
<li>
<p>hævede blodkar, som kan medføre hududslæt (vasculitis) og midlertidige nyreproblemer. </p>
</li>
<li>
<p>besvimelse, følelse af at være ved at besvime (synkope, præsynkope). </p>
</li>
</ul>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, bør du tale med din læge, apotekspersonalet eller sygeplejersken. Dette 
gælder også mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende 
kan også indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem 
anført i Appendiks V.<br />
Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere information om sikkerheden 
af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store fluad"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store fluad"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn. </p>
<p>Opbevares i køleskab (2 °C til 8 °C). Må ikke nedfryses. Kasseres, hvis vaccinen har været nedfrosset. 
Opbevar den fyldte injektionssprøjte i den ydre æske for at beskytte mod lys. </p>
<p>Brug ikke vaccinen efter den udløbsdato, der står på etiketten og på æsken efter EXP. Udløbsdatoen er 
den sidste dag i den nævnte måned. </p>
<p>Spørg apotekspersonalet, hvordan du skal bortskaffe medicinrester. Af hensyn til miljøet må du ikke 
smide medicinrester i afløbet, toilettet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Fluad Tetra indeholder: </p>
<p>Aktive stoffer<br />
- Influenzavirus-overfladeantigener (hæmagglutinin og neuraminidase), inaktiverede, fra 
følgende stammer*: </p>
<p>Pr. 0,5 ml-dosis 
A/Victoria/4897/2022 (H1N1)pdm09 - lignende stamme<br />
(A/Victoria/4897/2022 IVR-238) 
15 mikrogram HA<strong> 
A/Darwin/9/2021 (H3N2) - lignende stamme<br />
(A/Darwin/6/2021 IVR-227) 
15 mikrogram HA</strong> 
B/Austria/1359417/2021 - lignende stamme 
(B/Austria/1359417/2021 BVR-26) 
15 mikrogram HA<strong> 
B/Phuket/3073/2013 - lignende stamme 
(B/Phuket/3073/2013 BVR‐1B) 
15 mikrogram HA</strong> </p>
<p>*opformeret i befrugtede hønseæg fra raske kyllingeflokke og adjuveret med MF59C.1 </p>
<p>**hæmagglutinin </p>
<p>Vaccinen opfylder Verdensundhedsorganisationen (WHO’s) anbefalinger for den nordlige halvkugle 
samt EU’s bestemmelser for sæsonen 2023/2024. - MF59C.1 er indbefattet i denne vaccine som et adjuvans. Adjuvanser er stoffer, der inkluderes 
i visse vacciner for at accelerere, forbedre og/eller forlænge de beskyttende virkninger af 
vaccinen. MF59C.1 er et adjuvans, der pr. 0,5 ml-dosis indeholder: squalen (9,75 mg), 
polysorbat 80 (1,175 mg), sorbitantrioleat (1,175 mg), natriumcitrat (0,66 mg) og citronsyre 
(0,04 mg). </p>
<p>Øvrige indholdsstoffer 
- Natriumchlorid, kaliumchlorid, kaliumdihydrogenphosphat, dinatriumphosphatdihydrat, 
magnesiumchloridhexahydrat, calciumchloriddihydrat og vand til injektionsvæsker. </p>
<p>Udseende og pakningsstørrelser 
Fluad Tetra er en injektionsvæske, suspension i en fyldt injektionssprøjte. Fluad Tetra er en 
mælkehvid suspension. En enkelt sprøjte indeholder 0,5 ml injektionsvæske, suspension. Fluad Tetra 
findes i pakninger, der indeholder 1 eller 10 fyldte injektionssprøjter med eller uden kanyle.<br />
Ikke alle pakningsstørrelser er nødvendigvis markedsført.  </p>
<p>Indehaver af markedsføringstilladelsen og fremstiller 
Seqirus Netherlands B.V. 
Paasheuvelweg 28, 1105 BJ Amsterdam, Holland </p>
<p>Hvis du ønsker yderligere oplysninger om dette lægemiddel, skal du henvende dig til den lokale 
repræsentant for indehaveren af markedsføringstilladelsen: </p>
<p>België/Belgique/Belgien 
Seqirus Netherlands B.V. 
Nederland/Netherlands 
Tel: +31 (0) 20 204 6 
България 
Seqirus Netherlands B.V. Нидерландия 
Тел.: +31 (0) 20 204 6 
Česká republika 
Seqirus Netherlands B.V. Nizozemsko 
Tel: +31 (0) 20 204 6 
Danmark 
Seqirus Netherlands B.V. Holland 
Tlf: +31 (0) 20 204 6 
Deutschland 
Seqirus GmbH Marburg 
Tel: 0800/3601 
Eesti 
Seqirus Netherlands B.V. Holland 
Tel: +31 (0) 20 204 6 
Ελλάδα 
WIN MEDICA Α.Ε. 
Τηλ: +30 210 7488 
España 
Seqirus Spain, S.L., Barcelona 
Tel: 937 817<br />
France 
Seqirus Netherlands B.V. Netherlands 
Tél: +31 (0) 20 204 6 
Hrvatska 
Seqirus Netherlands B.V. Nizozemska 
Tel: +31 (0) 20 204 6 
Ireland 
Seqirus UK Limited Maidenhead 
Tel: +44 1628 641<br />
Ísland 
Seqirus Netherlands B.V. Holland 
Lietuva 
Seqirus Netherlands B.V. Nyderlandai 
Tel: +31 (0) 20 204 6 </p>
<p>Luxembourg/Luxemburg 
Seqirus Netherlands B.V. Netherlands 
Tél/Tel: +31 (0) 20 204 6 
Magyarország 
Seqirus Netherlands B.V. Hollandia 
Tel.: +31 (0) 20 204 6 
Malta 
Seqirus Netherlands B.V. In-Netherlands 
Tel: +31 (0) 20 204 6 
Nederland 
Seqirus Netherlands B.V. Amsterdam 
Tel: +31 (0) 20 204 6 
Norge 
Seqirus Netherlands B.V. Nederland 
Tlf: +31 (0) 20 204 6 
Österreich 
Valneva Austria GmbH, Wien 
Tel: +43 1 20620 2 
Polska 
Seqirus Netherlands B.V. Holandia 
Tel.: +31 (0) 20 204 6 
Portugal 
Seqirus Netherlands B.V. Países Baixos 
Tel: +31 (0) 20 204 6 
România 
Seqirus Netherlands B.V. Olanda 
Tel: +31 (0) 20 204 6 
Slovenija 
Seqirus Netherlands B.V. Nizozemska 
Tel: +31 (0) 20 204 6 
Slovenská republika 
Seqirus Netherlands B.V. Holandsko 
Sími: +31 (0) 20 204 6 
Italia 
Seqirus S.r.l. Siena 
Tel: +39 0577 096 
Κύπρος 
Seqirus Netherlands B.V. Ολλανδία 
Τηλ: +31 (0) 20 204 6 
Latvija 
Seqirus Netherlands B.V. Nīderlande 
Tel: +31 (0) 20 204 6 
Tel: +31 (0) 20 204 6 
Suomi/Finland 
Seqirus Netherlands B.V. Alankomaat 
Puh/Tel: +31 (0) 20 204 6 
Sverige 
Seqirus Netherlands B.V. Nederländerna 
Tel: +31 (0) 20 204 6 </p>
<p>Denne indlægsseddel blev senest ændret {MM/ÅÅÅÅ}. </p>
<p>Andre informationskilder </p>
<p>Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu. </p>
<hr />
<p>Nedenstående oplysninger er kun til sundhedspersoner: </p>
<p>Passende medicinsk behandling samt overvågning skal altid være let tilgængelig i tilfælde af en 
sjælden anafylaktisk reaktion efter administration af vaccinen. </p>
<p>Omrystes forsigtigt før brug. Efter omrystning fremstår vaccinen normalt som en mælkehvid 
suspension. </p>
<p>Vaccinen skal inspiceres visuelt for partikler og misfarvning før administration. Vaccinen må ikke 
administreres, hvis der observeres urenheder i form af partikler og/eller variation i fysisk 
beskaffenhed. </p>
<p>Når der anvendes en fyldt injektionssprøjte, der leveres uden en kanyle, fjernes hætten fra sprøjten, 
hvorefter en passende kanyle til administration fastgøres. Ved sprøjter med luer-lock fjernes hætten 
ved at skrue den af i retningen mod uret. Når hætten er fjernet, fastgøres en kanyle til sprøjten ved at 
skrue den på i retningen med uret, indtil den låser. Når kanylen er låst på plads, fjernes 
kanylebeskytteren, og vaccinen administreres. </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-2551c286e23d3921dbfab879452cee74
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for fluad Package Leaflet for language en"
Description: "ePI document Bundle for fluad Package Leaflet for language en"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-2551c286e23d3921dbfab879452cee74"
* entry[0].resource = composition-en-2551c286e23d3921dbfab879452cee74

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp2551c286e23d3921dbfab879452cee74"
* entry[=].resource = mp2551c286e23d3921dbfab879452cee74
                            
                    
Instance: bundlepackageleaflet-da-2551c286e23d3921dbfab879452cee74
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for fluad Package Leaflet for language da"
Description: "ePI document Bundle for fluad Package Leaflet for language da"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-2551c286e23d3921dbfab879452cee74"
* entry[0].resource = composition-da-2551c286e23d3921dbfab879452cee74

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp2551c286e23d3921dbfab879452cee74"
* entry[=].resource = mp2551c286e23d3921dbfab879452cee74
                            
                    



Instance: mp2551c286e23d3921dbfab879452cee74
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product fluad"
Description: "fluad"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/20/1433/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"


* indication = "Prophylaxis of influenza in adults 50 years of age and older."


* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"


* name
  * productName = "fluad"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#DK "DK"
    * jurisdiction = urn:iso:std:iso:3166#DK "DK"
    * language = urn:ietf:bcp:47#en  "en"




RuleSet: 2551c286e23d3921dbfab879452cee74ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "fluad"

* status = #current
* mode = #working

* title = "List of all ePIs associated with fluad"

* subject = Reference(mp354d06b758c1fa17f5a3268e4de6e468)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#fluad "fluad"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-2551c286e23d3921dbfab879452cee74) // fluad en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-2551c286e23d3921dbfab879452cee74) // fluad da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-2551c286e23d3921dbfab879452cee74
InstanceOf: List

* insert 2551c286e23d3921dbfab879452cee74ListRuleset
    